中文速读
本研究针对急性髓系白血病(AML),利用AML细胞系,通过Entranster-R4000转染siRNA沉默GPX1表达,发现GPX1高表达与不良预后相关,沉默GPX1降低细胞活力并影响免疫抑制相关基因表达。
体外(细胞)siRNAAML
GPX1-associated prognostic signature predicts poor survival in patients with acute myeloid leukemia and involves in immunosuppression
Affiliations
- 1 Key Laboratory of Endemic and Ethnic Diseases, Ministry of Education & Key Laboratory of Medical Molecular Biology of Guizhou Province, School of Basic Medical Science, Guizhou Medical University, Guiyang 550004, Guizhou, China.
- 2 Department of Pathophysiology, School of Basic Medical Sciences, Guizhou Medical University, Guiyang, Guizhou, China.
- 3 Medical Laboratory Center, the Third Affiliated Hospital of Guizhou Medical University, Duyun 558000, Guizhou, China. Electronic address: 842031616@qq.com.
- 4 Department of Pathophysiology, School of Basic Medical Sciences, Guizhou Medical University, Guiyang, Guizhou, China; Guizhou Provincial Key Laboratory of Pathogenesis and Drug Research on Common Chronic Diseases, Guiyang 550004, Guizhou, China. Electronic address: txch@gmc.edu.cn.
- 5 Department of Hematology, Guizhou Provincial People’s Hospital, Guizhou University, Guiyang 550002, Guizhou, China. Electronic address: gygpx118@sina.com.
- 6 Key Laboratory of Endemic and Ethnic Diseases, Ministry of Education & Key Laboratory of Medical Molecular Biology of Guizhou Province, School of Basic Medical Science, Guizhou Medical University, Guiyang 550004, Guizhou, China. Electronic address: 1507295114@qq.com.
- PMID: 34536536
- DOI: 10.1016/j.bbadis.2021.166268
Free article
Abstract
Objective: Treatment of acute myeloid leukemia (AML) remains a challenge. It is urgent to understand the microenvironment to improve therapy and prognosis.
Methods: Bioinformatics methods were used to analyze transcription expression profile of AML patient samples with complete clinical information from UCSC Xena TCGA-AML datasets and validate with GEO datasets. Western blot, qPCR, RNAi and CCK8 assay were used to assay the effect of GPX1 expression on AML cell viability and the expression of genes of interest.
Results: Our analyses revealed that highly expressed GPX1 in AML patients links to unfavorable prognosis. GPX1 expression was positively associated with not only fraction levels of myeloid-derived suppressor cells (MDSCs), monocytes and T cell exhaustion, the expression levels of MDSC markers, MDSC-promoting CCR2 and immune inhibitory checkpoints (TIM3/Gal-9, SIRPα and VISTA), but also negatively with low fraction levels of CD4+ and CD8+ T cells. Silencing GPX1 expression reduced AML cell viability and CCR2 expression. Moreover, GPX1-targetd kinases were PKC family, SRC family, SYK and PAK1, which promote AML progression and the resistance to therapy. Furthermore, Additionally, GPX1-associated prognostic signature (GPS) is an independent risk factor with high area under curve (AUC) values of receiver operating characteristic (ROC) curves. High risk group based on GPS enriched not only with endocytosis which transfers mitochondria to favor AML cell survival in response to chemotherapy, but also NOTCH, WNT and TLR signaling which promote therapy resistance.
Conclusion: Our results revealed the significant involvement of GPX1 in AML immunosuppression via and provided a prognostic signature for AML patients.
Keywords: Acute myeloid leukemia; CCR2; GPX1; Immunosuppresion; Myeloid derived suppressor cells; Prognosis; SIRPα/CD47; TIM3/Gal-9; VISTA.
小核酸转染试剂Entranster™-R4000 已有 223 篇已发表文献
同类研究
- J Ovarian Res. 2026 Jul 31;19(1):330.doi: 10.1186/s13048-026-02215-6. Microfluidic lipid nanoparticles co-delivering siM…
- Front Immunol. 2026 May 29;17:1724930.doi: 10.3389/fimmu.2026.1724930. Machine learning-based identification of an oxida…
- Cell Calcium. 2026 Apr 19:135:103137.doi: 10.1016/j.ceca.2026.103137. TRPC1 channel modulates mechanical stretch-induced…
- Pharmaceuticals (Basel). 2026 Mar 27;19(4):540.doi: 10.3390/ph19040540. Identification of Dopamine D2 Receptor as a Dire…
- Viruses. 2026 Mar 5;18(3):323.doi: 10.3390/v18030323. Tree Shrew Genome-Wide CRISPR Screen Identifies RNF6 as a Proviral…